Path Ex

Houston, TX · Founded 2017 · Privately Held (backing)

Developer of an extracorporeal blood-cleansing device designed for the diagnosis and treatment of sepsis. Path Ex is based in Houston, TX and was founded in 2017. It was valued at $31 million at its seed round in Apr 2025, the last priced event on record. It has raised $12.5 million across 1 recorded round; the latest was an $8.2 million early-stage round in Apr 2025.

PMV mark · valuation
$31.0M
Oct 2026
Priced at
its seed round
Apr 2025
Total raised
$12.5M
Last round
Early Stage VC
Apr 2025
Cap table — not yet on record

Path Ex's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Path Ex with a free account
  • ·The complete investor list: 18 names
  • ·Watch Path Ex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Path Ex

Where does Path Ex's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Path Ex's 1 recorded funding rounds.